Conference
Immunotherapy with donor lymphocytes depleted of anti-host reactive cells results in safe and efficacious haploidentical HSCT: interim results from a phase II trial in patients with hematologic malignancies
Authors
Roy D; Maertens J; Walker I; Foley R; Lewalle P; Selleslag D; Velthuis J; Gerez L; Reitsma K; Wagena E
Volume
16
Publisher
Elsevier
Publication Date
April 2014
DOI
10.1016/j.jcyt.2014.01.085
Conference proceedings
Cytotherapy
Issue
4
ISSN
1465-3249